Remimazolam and Esketamine for Older Adults Having Painless Stomach and Colon Scope
Part of Digestive system clinical trials.
This trial tests a combination of two sedative medicines (Remimazolam and Esketamine) for elderly patients having a painless stomach and colon exam. The goal is to see if this combination is safe and effective for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You are having a painless stomach and/or colon scope exam (gastroscopy/colonoscopy) as an outpatient.
- You are in overall good health (ASA grade I, II, or III).
- You do not have serious liver or kidney problems.
- You do not have uncontrolled high blood pressure or serious heart disease.
- You are not currently taking certain medicines like strong sedatives, antidepressants, or antipsychotics.
- You do not have a history of heavy smoking or alcohol addiction.
- You are not allergic to the study medicines (Remimazolam or Esketamine).
- Your body mass index (BMI) is 35 or lower.
- You have not been in another clinical trial in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
This trial studies a sedative called remimazolam and how it makes people feel during routine upper and lower GI scope procedures. It may help doctors understand which patients are more likely to feel a sense of euphoria (a feeling of intense happiness) from the medicine.
This study tests two different sedative medicines to see which one helps children aged 6 to 12 breathe more safely during a gastroscopy (a scope test to look at the stomach). It compares a new drug, esketamine, with a combination of remazolam and propofol to find the one with fewer breathing problems.
This study tests whether a combination of two medicines (esketamine and remimazolam) can help people sleep better and feel less anxious after surgery. Researchers want to see if this approach works better than standard care.
This trial compares two sedative medications, Remimazolam and Propofol, to see which works better for upper GI endoscopy exams and treatments. The goal is to help doctors choose the best option for patients.
Hear when a new Gastrointestinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.